Stock Track | Fresenius Medical Care Plunges 6% on Disappointing 2026 Guidance

Stock Track
Feb 24

Fresenius Medical Care AG & Co. KGaA's stock experienced a significant intraday decline of 6.02%.

The plunge follows the company's 2026 financial guidance, which analysts at Jefferies describe as likely to disappoint. The German dialysis specialist forecast broadly flat revenue for the year, with adjusted operating profit expected to range from a mid-single-percentage digit rise to a fall of the same proportion. Despite an anticipated €250 million in savings from an efficiency program, this outlook suggests intensifying headwinds are offsetting these gains.

Furthermore, the company reiterated its 2030 profitability target even after raising its savings goal for 2027, a move that may have contributed to investor concerns about underlying business challenges.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10